Genmab A/s (GMAB) stock trades by Congress
Sector: Health care & pharma
Members of Congress disclosed 3 trades in Genmab A/s (GMAB) between Dec 2024 and Mar 2026: 2 purchases and 1 sale by 2 members. The most active were Josh Gottheimer (D-NJ, 2 trades) and Alan Armstrong (R-OK, 1 trade). The latest trade listed here is from March 30, 2026.
- Trades (2 years)
- 3
- Purchases
- 2
- Sales
- 1
- Members
- 2
Democrat Democrats: 2Republican Republicans: 1
Which members of Congress traded GMAB?
Latest GMAB trades by members of Congress
The 3 most recent trades older than 60 days, as filed: amounts are the disclosed ranges.
| Member | Trade | Amount | Traded | Disclosed |
|---|---|---|---|---|
| Alan ArmstrongR-OK · Senate | Buy | $1K–15K | Mar 30, 2026 | Jul 21, 2026 |
| Josh GottheimerD-NJ · House | Buy | $1K–15K | Jan 16, 2025 | Feb 10, 2025 |
| Josh GottheimerD-NJ · House | Sell | $1K–15K | Dec 16, 2024 | Jan 14, 2025 |
Frequently asked questions
- Which members of Congress traded GMAB?
- 2 members of Congress disclosed trades in Genmab A/s (GMAB) in the last two years, led by Josh Gottheimer (2 trades) and Alan Armstrong (1 trade).
- Is Congress buying or selling GMAB?
- Members have mostly been buying GMAB: 2 purchases and 1 sale. Democrats made 2 trades and Republicans 1 trade.
- When did a member of Congress last trade GMAB?
- The latest trade listed here is from March 30, 2026. Members have up to 45 days to disclose a trade, so newer ones appear as they are filed.